Terrie Kellmeyer
Patrimonio netto: - $ in data 31/05/2026
Patrimonio netto: - $ in data 31/05/2026
Terrie Kellmeyer is currently Chief Executive Officer at Anavex Life Sciences Corp., a position starting in 2026.
Former roles include Senior Vice President-Regulatory Affairs at Aardvark Therapeutics, Inc. from 2025 to 2026, Group Vice President-Clinical Development at Acer Therapeutics, Inc., and Head-Global Regulatory Affairs at Madrigal Pharmaceuticals, Inc. Education includes an undergraduate degree from Rochester Institute of Technology and a doctorate from The State University of New York.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 04/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ANAVEX LIFE SCIENCES CORP. | Amministratore Delegato | 04/05/2026 |
| Società | Posizione | Fine |
|---|---|---|
| AARDVARK THERAPEUTICS, INC. | Consigliere Generale | 01/05/2026 |
| ACER THERAPEUTICS INC. | Direttore Tecnico/Scientifico/R&S | - |
| MADRIGAL PHARMACEUTICALS, INC. | Consigliere Generale | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
Rochester Institute of Technology
Rochester Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The State University of New York
The State University of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anavex Life Sciences Corp.
Anavex Life Sciences Corp. BiotechnologyHealth Technology Engages in the development of innovative drug compounds | Health Technology |
Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small-molecule drugs for cardiovascular, metabolic and liver diseases | Health Technology |
Acer Therapeutics, Inc.
Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes therapies for serious rare and life-threatening diseases | Health Technology |
Aardvark Therapeutics, Inc.
Aardvark Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel small molecule therapeutics for obesity and metabolic diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale